Determining What Expertise Is Needed In A Partnered Drug Development Model

Rob Wright, chief editor of Life Science Leader, conducted an executive virtual roundtable with Pamela Contag, Ph.D., cofounder and CEO of BioEclipse Therapeutics, a clinical-stage oncology company; and Dara Lockert, founder and executive director of Spannerwerks, a life science industry consultancy (view full video here). In this snippet, Contag and Lockert chat about strategic versus tactical expertise, and figuring out what needed internally versus what could be outsourced. For more information be sure to read the wisdom shared by Contag in, “A Small Biopharma’s View Of Working With CROs,” published in the July 2020 CRO Leadership Awards special supplement.